Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 75 for “"Biochemical recurrence"”.

  1. Risk prediction models for biochemical recurrence after radical prostatectomy

    … developed, including models for prediction of biochemical recurrence (BCR). However, models for individual BCR-free probability at individual time- points after a BCR-free period are rare. Material and Methods: Follow-up data from 1575 patients who underwent laparoscopic radical prostatectomy …

    fu-berlin Repository record for Risk prediction models for biochemical recurrence after radical prostatectomy (opens in a new tab)

  2. Soy Isoflavone Supplementation and Biochemical Recurrence After Curative Treatment for Localized Prostate Cancer

    … treatment for localized prostate cancer on biochemical recurrence has not been evaluated. Objective: To determine if short-term supplementation with soy isoflavones prior to curative treatment delays or prevents biochemical recurrence in men with localized prostate cancer. Design: Electronic …

    ku Repository record for Soy Isoflavone Supplementation and Biochemical Recurrence After Curative Treatment for Localized Prostate Cancer (opens in a new tab)

  3. Tissue-based microRNAs as predictors of biochemical recurrence after radical prostatectomy: What can we learn from past studies?

    … may be helpful novel molecular biomarkers of biochemical recurrence for a more accurate risk stratification of PCa patients after radical prostatectomy and may contribute to personalized treatment. Tissue samples from prostatectomy specimens are easily available for miRNA isolation. Numerous …

    fu-berlin Repository record for Tissue-based microRNAs as predictors of biochemical recurrence after radical prostatectomy: What can we learn from past studies? (opens in a new tab)

  4. Development of an immuno-mass spectrometric assay for validation of protein C inhibitor (PCI) as a biomarker for prediction of biochemical recurrence in prostate cancer patients

    … C inhibitor (PCI) as a marker for prediction of biochemical recurrence in prostate cancer patients. The PCI-specific analyte was shown to predict biochemical recurrence of prostate cancer after radiation/hormone treatment. Early stage detection of recurrence was achieved, when compared to the …

    uvic Repository record for Development of an immuno-mass spectrometric assay for validation of protein C inhibitor (PCI) as a biomarker for prediction of biochemical recurrence in prostate cancer patients (opens in a new tab)

  5. Impact of Obesity and Expression of Obesity-Related Genes in the Progression of Prostate Cancer in African American Men

    … American men. The primary outcome of interest is biochemical recurrence (BCR) of PCa. There were 48 African American prostate cancer patients in the study. The tissue samples included 42 normal tissues, 40 Prostate Intraepithelial Neoplasia (PIN) and 45 tumor tissues (127 tissue samples in total). …

    usf Repository record for Impact of Obesity and Expression of Obesity-Related Genes in the Progression of Prostate Cancer in African American Men (opens in a new tab)

  6. Determining the trajectories of men presenting with Gleason Score 6 prostate cancer using risk alleles and somatic copy number aberrations

    … new local or distal disease detectable as a biochemical recurrence. I aim to use genetic predisposition markers and somatic copy number aberrations to identify which of these men will undergo biochemical recurrence post RP. <br/>In order to identify which men will develop a biochemical …

    kings Repository record for Determining the trajectories of men presenting with Gleason Score 6 prostate cancer using risk alleles and somatic copy number aberrations (opens in a new tab)

  7. Genų polimorfizmų reikšmė priešinės liaukos vėžio biocheminio recidyvo atsiradimui /

    … Role of Gene Polymorphisms in the Development of Biochemical Recurrence of Prostate Cancer Prostate cancer (PC) is the second most common type of oncological diseases in the world, and the sickness rate is steadily increasing. Radical prostatectomy (RP) is still the main treatment method. Though, …

    vilnius Repository record for Genų polimorfizmų reikšmė priešinės liaukos vėžio biocheminio recidyvo atsiradimui / (opens in a new tab)

  8. Η προγνωστική αξία των πρωτεϊνών P53 και P21 σε ασθενείς με καρκίνο του προστάτη μετά από ριζική προστατεκτομή

    … immunoreactivity andp21 immunoreactivity with biochemical recurrence after radicalprostatectomy.Materials and Methods: P53 protein expression and p21 were evaluated on84 archival paraffin-embedded radical prostatectomy specimens. Patientswere divided into 2 groups for p533: patients with low …

    greece Repository record for Η προγνωστική αξία των πρωτεϊνών P53 και P21 σε ασθενείς με καρκίνο του προστάτη μετά από ριζική προστατεκτομή (opens in a new tab)

  9. Epigenetic Analysis of the Kallikrein Gene Family and Associated Pathways as a Novel Panel of Prostate Cancer Biomarkers

    … with pathological stage and longer time to biochemical recurrence in two independent cohorts of PCa patients. KLK6 hypermethylation was observed in normal-appearing prostate tissue adjacent to PCa, which could be indicative of the epigenetic field effect. Through the use of qPCR microRNA …

    toronto-retro Repository record for Epigenetic Analysis of the Kallikrein Gene Family and Associated Pathways as a Novel Panel of Prostate Cancer Biomarkers (opens in a new tab)

  10. Diagnostic and Prognostic Biomarkers for Early Prostate Cancer

    … associated with prostate cancer grade group and biochemical recurrence. Loss of the PTEN tumor suppressor is a powerful prognostic biomarker in prostate cancer. However, the significance of tumour heterogeneity and partial PTEN loss are not clearly defined, nor are interactions between PTEN loss …

    queens Repository record for Diagnostic and Prognostic Biomarkers for Early Prostate Cancer (opens in a new tab)

  11. Identifying features of the immune microenvironment related to lifestyle and prostate cancer progression

    … identified between histologic inflammation and biochemical recurrence of prostate cancer in UNC CSC and FASTMAN cohorts. Enrichment of immunosuppressive T cell subsets, such as T-regulatory cells and exhausted CD4+ T cells, along with potential tumour-associated macrophages (estimated by gene …

    qu-belfast Repository record for Identifying features of the immune microenvironment related to lifestyle and prostate cancer progression (opens in a new tab) Embargoed until 2027-12-31

  12. Imunologiniai atvirų ir laparoskopinių prostatos vėžio operacijų skirtumai /

    … lympho-node status) as well as the risk of biochemical recurrence. We found, that Laparoscopic Radical Prostatectomy (LPR) technique resulted in complete restoration of T cell, NK, CTL. Also the immunosuppressive compartment (MDSC) did not reveal any upregulation in the postoperative period …

    vilnius Repository record for Imunologiniai atvirų ir laparoskopinių prostatos vėžio operacijų skirtumai / (opens in a new tab)

  13. Evaluation of multi-parametric Magnetic Resonance Imaging for the detection of prostate cancer

    … in prostate biopsy and risk estimation of PCa recurrence called biochemical recurrence (BCR). Material and Methods: Institutional review board approval and informed consent were obtained in all studies. In the first study ex vivo intact-tissue spectroscopy at 14 T was used to estimate the risk …

    fu-berlin Repository record for Evaluation of multi-parametric Magnetic Resonance Imaging for the detection of prostate cancer (opens in a new tab)

  14. Η συσχέτιση ορμονικών και μεταβολικών παραγόντων με την επιθετικότητα της νόσου σε ασθενείς με κλινικά εντοπισμένο καρκίνο του προστάτη

    … according to the TNM staging system, and PSA biochemical recurrence (BCR) after surgery. Results: In total, 91 patients were enrolled. The mean age and PSA was 64.8 years and 9.3 ng/dl, respectively. The median post-operative GS was 7. Low AMH blood levels were correlated with higher …

    greece Repository record for Η συσχέτιση ορμονικών και μεταβολικών παραγόντων με την επιθετικότητα της νόσου σε ασθενείς με κλινικά εντοπισμένο καρκίνο του προστάτη (opens in a new tab)

  15. Analysis of RNA in bodily fluids for prostate cancer diagnosis and outcome prediction /

    … of miR-19b and miR-19a/b specifically predicts biochemical recurrence. Castration resistant prostate cancer (CRPC) remains incurable. Due to the heterogeneous nature of CRPC, approximately 30% of patients are already resistant to these new drugs. In patients treated with abiraterone acetate …

    vilnius Repository record for Analysis of RNA in bodily fluids for prostate cancer diagnosis and outcome prediction / (opens in a new tab)

  16. Organizmo skysčių RNR tyrimai prostatos vėžio diagnostikai ir ligos eigos prognozavimui /

    … of miR-19b and miR-19a/b specifically predicts biochemical recurrence. Castration resistant prostate cancer (CRPC) remains incurable. Due to the heterogeneous nature of CRPC, approximately 30% of patients are already resistant to these new drugs. In patients treated with abiraterone acetate …

    vilnius Repository record for Organizmo skysčių RNR tyrimai prostatos vėžio diagnostikai ir ligos eigos prognozavimui / (opens in a new tab)

Page 1 of 4